Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07164131 · ClinicalTrials.gov registry record · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
A Phase 4 study of Community-acquired Pneumonia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,120
- Enrollment target
- 5
- Study locations
NCT07164131: Recruiting Phase 4 study of Community-acquired Pneumonia, sponsored by Mayo Clinic.
NCT07164131 is a Phase 4 study of Community-acquired Pneumonia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,120 participants, below the 108,997-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07164131, a Phase 4 study of Community-acquired Pneumonia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,120 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
Primary Outcome
Number of days subject remained out of hospital
Conditions Studied
Interventions
- DRUG Azithromycin
- DRUG Doxycycline
Study Locations (5)
Minnesota
- Mayo Clinic Health System-Mankato - Mankato
- Mayo Clinic in Rochester - Rochester
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Wisconsin
- Mayo Clinic Health System-La Crosse - La Crosse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,120 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2031-09-01 |
| Phase | Phase 4 |
What NCT07164131 shows while recruiting
NCT07164131 is an interventional study that assigns participants to a tested intervention. Its 1,120 participants enrollment target places it among the larger protocols in the corpus, below the 108,997-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Community-acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Azithromycin is the first listed.
NCT07164131 lists 5 locations in 4 states (Minnesota, Arizona, Florida).
Frequently Asked Questions
What is clinical trial NCT07164131 about?
NCT07164131 is a clinical study titled "Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams". The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
What is the current status of trial NCT07164131?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,120 participants. The study started on 2025-09-15. Estimated completion is 2031-09-01.
What conditions does trial NCT07164131 study?
This clinical trial studies the following conditions: Community-acquired Pneumonia.
What interventions are being tested in trial NCT07164131?
The interventions under investigation include: Azithromycin (DRUG), Doxycycline (DRUG).
Who is sponsoring clinical trial NCT07164131?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07164131 being conducted?
This trial has 5 study locations across Arizona, Florida, Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Community-acquired Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07164131's enrollment target sits among peer trials
1,120 6th of 9 higher than 4 of 9 other Community-acquired Pneumonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Community-acquired Pneumonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
RECRUITING · NA
-
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
RECRUITING · Phase 3
-
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
RECRUITING · Phase 3
-
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
RECRUITING
-
Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
RECRUITING · NA
-
Discharge Stewardship in Children's Hospitals
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI